Similar articles

• Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).

  Samama MM. Samama MM. Adv Exp Med Biol. 1992;313:275-81. doi: 10.1007/978-1-4899-2444-5_27. Adv Exp Med Biol. 1992. PMID: 1332441 Review. No abstract available.
• Report on the International Symposium on Low Molecular Weight Heparins and Related Polysaccharides. Munich, Germany, June 27 and 28, 1991.

  Haas P. Haas P. Semin Thromb Hemost. 1993;19 Suppl 1:217-26. Semin Thromb Hemost. 1993. PMID: 8395724 No abstract available.
• Can the bleeding potential of low molecular weight heparins be assessed and minimized in postsurgery prophylaxis?

  Toulemonde F. Toulemonde F. Semin Thromb Hemost. 1991 Oct;17(4):351-5. doi: 10.1055/s-2007-1002634. Semin Thromb Hemost. 1991. PMID: 1666455 Review. No abstract available.
• Low molecular weight heparins and bleeding.

  Breddin HK. Breddin HK. Semin Thromb Hemost. 1989 Oct;15(4):401-4. doi: 10.1055/s-2007-1002738. Semin Thromb Hemost. 1989. PMID: 2479104 Review. No abstract available.
• Effectiveness and safety of low molecular weight heparins (LMWH) in the prevention of venous thromboembolism (VTE).

  Kakkar VV. Kakkar VV. Thromb Haemost. 1995 Jul;74(1):364-8. Thromb Haemost. 1995. PMID: 8578486